IQVIA Digital Site Suite

  1. Orchestrated Study Start-Up 10/16/2023

    Learn how the IQVIA Investigator Site Portal reduces activation timelines and eliminates site frustrations by automating processes and providing complete oversight to study teams.

  2. Practical Approaches To Faster Study Start-Ups 9/25/2023

    Learn how teams can leverage organizational, procedural, and technological solutions to recapture valuable days, weeks, and even months in the activation timelines of research sites.

  3. The Impact Of Clinical Trial Payments On Site-Sponsor Relationships 7/18/2023

    The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.

  4. Crowdsource UAT: An Opportunity For Future Validation 6/28/2023

    IQVIA, a leading health information technology and clinical research company, has introduced a new validation model for eTMF patterned after approaches used within the larger tech space.

  5. Reduce Workloads And Improve Insights With Crowdsource UAT 6/28/2023

    Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.

  6. Achieving Faster, Simpler Validation Through Crowdsource UAT 6/28/2023

    An approach most often seen in the larger tech space, crowdsource UAT can offer several potential advantages for the clinical trial industry and eTMF validation.

  7. Q&A About Bristol Myers Squibb’s Consolidated Site Payments Strategy 6/27/2023

    How do payment systems affect site-sponsor relationships? George Kourtsounis of Bristol Myers Squibb and Casey Orvin of CenExel Clinical Research lend their expertise to this question and more.

  8. Routes To Sponsor Of Choice: Shared Pipelines, Streamlined Payments 6/27/2023

    Paying clinical trial sites consistently on time provides stability and maintains positive relationships. Learn why being a sponsor of choice can mean the adoption of a singular clinical trial payments solution.

  9. Trends In Sponsor-Of-Choice Initiatives: Consolidating Site Payments 5/5/2023

    Listen in as leaders from Bristol Myers Squibb, CenExel Centers of Excellence, and IQVIA Technologies discuss the importance of providing a consistent clinical trial payment experience to sites.

  10. How To Budget For Site Payments Success 4/27/2023

    Unearth how bringing the functions of medical writing, clinical data management, and electronic data capture can positively impact the creation of a budget and payment process.